1) Beiske AG, Loge JH, Rønningen A, et al:Pain in Parkinson's disease:Prevalence and characteristics. Pain 141:173-177, 2009
2) Di Chiara G, Imperato A:Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080, 1988
3) Ford B:Pain in Parkinson's disease. Mov Disord 25:S98-103, 2010
4) Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al:Levodopa raises objective pain threshold in Parkinson's disease:a RIII reflex study. J Neurol Neurosurg Psychiatry 78:1140-1142, 2007
5) Haber SM, Knutson B:The reward circuit:Linking primate anatomy and human imaging. Neuropsychopharma 35:4-26, 2010
6) 半場道子:痛みの新しい視点:mesolimbic dopamine system.ペインクリニック33:229-238,2012
7) Ilango A, Kesner AJ, Keller KL, et al:Similar roles of substantia nigro and ventral tegmental dopamine neurons in reward and aversion. J Neurosci 34:817-822, 2014
8) Jarcho JM, Mayer EA, Jiang K, et al:Pain, affective symptoms and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153:744-754, 2012
9) Leknes S, Tracey I:A common neurobiology for pain and pleasure. Nature Rev Neurosci 9:314-320, 2008
10) Nègre-Pagès L, Regragui W, Bouhassira D, et al:Chronic pain in Parkinson's disease:The cross-sectional French DoPaMiP survey. Mov Disord 23:1361-1369, 2008
11) 日本神経学会(監修)「パーキンソン病治療ガイドライン」.作成委員会(編集):パーキンソン病治療ガイドライン2011.医学書院,東京,2011
12) Rana AQ, Saeed U, Masroor MS, et al:A cross-sectional study investigating clinical predictors and physical experiences of pain in Parkinson's disease. Functional Neurol 28:297-304, 2013
13) Rana AQ, Qureshi AR, Rahman L, et al:Association of restless legs syndrome, pain, and mood disorders in Parkinson's disease. Int J Neurosci 3:1-13, 2014
14) Scott DJ, Heitzeg MM, Koeppe RA, et al:Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci 26:10789-10795, 2006